Trial intelligence / Profile preview

Zhichuanling oral liquid for bronchial asthma

ChiCTR2000031514Phase 4Completed

Sponsor
China-Japan Friendship Hospital
Start
Sep 2019
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Zhichuanling in asthma (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Asthma control rate. Started Sep 2019; status: completed.

02

Drugs

Zhichuanling
03

Conditions

asthma

Beyond the preview

Go deeper on ChiCTR2000031514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000031514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call